GOOD NEWS! Researchers at Stanford University have developed a UNIVERSAL vaccine known as GLA-3M-052-LS+OVA, that protects against a wide range of respiratory viruses, bacteria AND even allergens. The vaccine is delivered intranasally AND provides broad protection in the lungs for several MONTHS.
Goodbye to seasonal viruses as we know them: the first universal vaccine against respiratory infections and allergies is now closer than ever
Scientists are getting closer to a universal nasal vaccine that could protect against respiratory viruses, bacteria and even allergies
www.ecoticias.com
Goodbye to seasonal viruses as we know them: the first universal vaccine against respiratory infections and allergies is now closer than ever
Scientists are getting closer to a universal nasal vaccine that could protect against respiratory viruses, bacteria and even allergies
www.ecoticias.com
quoted said:For more than 230 years, most vaccines have followed the same basic rule. They teach the immune system to recognize a specific antigen, which works well when the target stays relatively stable, but it becomes more complicated when viruses like influenza
quoted said:Stanford’s experimental formula, called GLA-3M-052-LS+OVA, takes a different path. It combines molecules that stimulate Toll-like receptors 4 and 7/8 with ovalbumin, a harmless egg protein, so the vaccine can mimic immune “danger signals” and draw T cells into the lungs. In practical terms, the goal is to keep broad local defenses switched on longer, right where many infections first gain a foothold.
What the mouse results actually showed
In the mouse experiments, the vaccine was delivered through the nose, and some animals received multiple doses one week apart. After three doses, mice were protected against [the flu] and other viruses for at least three months, and the amount of virus in their lungs fell by about 700-fold compared with unvaccinated animals.

